Spero Therapeutics Stock Options
| SPRO Stock | USD 2.32 0.05 2.11% |
Spero Therapeutics' latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 1.84 with a put-to-call open interest ratio of 0.98 over 6 outstanding agreements suggesting . The Spero Therapeutics option chain provides detailed quote and price information for the current Spero Therapeutics option contracts. It shows all of Spero Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against October 17th 2025 Option Contracts
2025-10-17
The chart above shows Spero Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Spero Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Spero Therapeutics' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Spero Therapeutics
Analyzing Spero Therapeutics' in-the-money options over time can help investors to take a profitable long position in Spero Therapeutics regardless of its overall volatility. This is especially true when Spero Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Spero Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Spero Therapeutics' stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Spero Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Spero Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Spero Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Spero Stock moves the wrong way.
Spero Current Options Market Mood
Spero Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Spero Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Spero Therapeutics' options investors are not very successful. Spero Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Spero contract
Base on the Rule 16, the options market is currently suggesting that Spero Therapeutics will have an average daily up or down price movement of about 0.12% per day over the life of the 2025-10-17 option contract. With Spero Therapeutics trading at USD 2.32, that is roughly USD 0.002668. If you think that the market is fully incorporating Spero Therapeutics' daily price movement you should consider buying Spero Therapeutics options at the current volatility level of 1.84%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Spero Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Spero calls. Remember, the seller must deliver Spero Therapeutics stock to the call owner when a call is exercised.
Spero Therapeutics Option Chain
When Spero Therapeutics' strike price is surpassing the current stock price, the option contract against Spero Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Spero Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Spero. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Spero. It also shows strike prices and maturity days for a Spero Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | SPRO251017C00007500 | 173 | 7.5 | 0.0 - 0.05 | 0.1 | Out |
Call | SPRO251017C00005000 | 1915 | 5.0 | 0.05 - 0.4 | 0.09 | Out |
Call | SPRO251017C00002500 | 1167 | 2.5 | 0.35 - 0.5 | 0.35 | Out |
Put | SPRO251017P00007500 | 0 | 7.5 | 2.8 - 6.1 | 2.8 | In |
Put | SPRO251017P00005000 | 21 | 5.0 | 1.6 - 3.6 | 2.48 | In |
Put | SPRO251017P00002500 | 3175 | 2.5 | 0.25 - 0.55 | 0.45 | In |
Spero Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Spero Total Stockholder Equity
Total Stockholder Equity |
|
Spero Therapeutics Corporate Management
| Satyavrat CFA | CFO Treasurer | Profile | |
| James Brady | Chief Officer | Profile | |
| Ted Jenkins | VP Relations | Profile | |
| Ian Critchley | Head Microbiology | Profile | |
| Sheila Finan | Senior Controller | Profile | |
| John Raymond | Senior Operations | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spero Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Spero Stock, please use our How to Invest in Spero Therapeutics guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spero Therapeutics. If investors know Spero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.753 | Earnings Share (1.28) | Revenue Per Share | Quarterly Revenue Growth (0.37) | Return On Assets |
The market value of Spero Therapeutics is measured differently than its book value, which is the value of Spero that is recorded on the company's balance sheet. Investors also form their own opinion of Spero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spero Therapeutics' market value can be influenced by many factors that don't directly affect Spero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.